Catalyst
Monitor the trial's progress, particularly the outcomes related to self-care and hospitalization rates, as well as the adoption of the digital health application.
Date
June 20, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.